RT @drdavidliew: ORAL Surveillance: MACE and malignancy are getting all the attention... but did you know that non-zost
Tweet Content
ORAL Surveillance: MACE and malignancy are getting all the attention...
but did you know that non-zoster infections are also more likely with tofacitinib vs TNFis?
#ACR21 ABST1684 @RheumNow https://t.co/GiBkvPYs4j
Show on Archive Page
On
Display in Search Results
On
PDQ
Off